FDA Webview
X

Free FDA Notices

Panel to Discuss Donor Deferral to Reduce Creutzfeldt-Jakob Disease

07/01/2011

Federal Register Notice: FDA’s Transmissible Spongiform Encephalopathies Advisory Committee will meet 8/1, from 9 a.m. to about 4:30 p.m. at the Hilton Hotel, Washington DC North Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss donor deferral for time spent in Saudi Arabia to reduce the risk of variant Creutzfeldt-Jakob disease by blood and blood products and human cells, tissues and cellular and tissue-based products. Contact Bryan Emery or Rosanna Harvey, (301) 827-0314. To view this notice, click here.

LATEST NEWS